8-K ·Filed Apr 17, 2026

VXRT

Vaxart, Inc.
BEARISH
Impact 6/10
Horizonweeks Processed5mo ago SEC0001437749-26-012623
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ▼ Bearish

Monitor for initial share sales under this agreement, which would signal immediate dilution. The 447,067 commitment shares represent immediate dilution of approximately 1.5% based on current share count. Watch for registration statement filing as the next catalyst.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
VXRT ▼ -26.67% at T+60d
SHORT call ✓ call won +26.67% · α vs SPY +32.81% · entry $0.7500 → $0.5500
Entry anchored
Apr 17, 2026
via day open
T+1d
+1.33%
call -1.33% · α -1.52%
$0.7600
settled 6mo ago
T+5d
-4.00%
call +4.00% · α +4.55%
$0.7200
settled 5mo ago
T+20d
-13.33%
call +13.33% · α +18.70%
$0.6500
settled 5mo ago
T+60d
-26.67%
call +26.67% · α +32.81%
$0.5500
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Vaxart entered into a $25 million equity line agreement with Lincoln Park Capital, allowing it to sell shares over 24 months. The company issued 447,067 commitment shares to Lincoln Park and will file a registration statement for resale. Lincoln Park agreed not to engage in short selling.

Key Financial Metrics

Deal Value
$25.0M
Deal Type
credit_facility
Offering Size
$25.0M
Dilution
1.5%

Key Facts

  • Vaxart entered into a $25 million equity line agreement with Lincoln Park Capital
  • Company issued 447,067 commitment shares to Lincoln Park as consideration
  • Lincoln Park agreed not to engage in short selling or hedging transactions
  • Company has full discretion over timing and amount of share sales
  • Proceeds will be used for working capital, capital expenditures, and general corporate purposes

Financial Impact

Up to $25 million in potential dilution through equity financing

dilutioncashequity

Risk Factors

  • Significant shareholder dilution from potential $25 million in share sales
  • Downward pressure on stock price from regular share issuance
  • Company may be perceived as desperate for capital given OTC listing

Market Snapshot

Exchange
OTC
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-012623
Exhibit: ex_947187.htm0001437749-26-012623
Exhibit: ex_947188.htm0001437749-26-012623
Document: vxrt20260417_8k.htm0001437749-26-012623
Document: 0001437749-26-012623-index-headers.html0001437749-26-012623
Document: 0001437749-26-012623-index.html0001437749-26-012623
Document: 0001437749-26-012623.txt0001437749-26-012623
21 reports for VXRT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for VXRT — sortable, filterable
TypeNow
Jul 28, 2026
9w ago
8-K
NEUTRAL ★ 2/10
$0.4800 $0.5000▲ +4.17%▲ +0.79%$0.4400 (−8.33%)
Jul 7, 2026
12w ago
8-K
NEUTRAL ★ 4/10
$0.5500 $0.6000▲ +9.09%▲ +5.93%$0.4400 (−20.00%)
Jul 6, 2026
12w ago
DEFA14A
NEUTRAL ★ 5/10
$0.6200 $0.5900▼ −4.84%▼ −5.69%$0.4400 (−29.03%)
Jul 2, 2026
13w ago
DEFA14A
BULLISH ★ 5/10
$0.6400 $0.5490▼ −14.22%▼ −14.52%$0.4400 (−31.25%)
Jul 2, 2026
13w ago
8-K
NEUTRAL ★ 4/10
$0.6400 $0.5200▼ −18.75%▼ −18.34%$0.4400 (−31.25%)
Jun 26, 2026
13w ago
DEFA14A
NEUTRAL ★ 4/10
$0.5700 $0.4501▼ −21.04%▼ −20.78%$0.4400 (−22.81%)
Jun 26, 2026
13w ago
DEFA14A
NEUTRAL ★ 3/10
$0.5700 $0.4501▼ −21.04%▼ −20.78%$0.4400 (−22.81%)
Jun 26, 2026
13w ago
8-K
MIXED ★ 5/10
$0.5700 $0.4501▼ −21.04%▼ −20.78%$0.4400 (−22.81%)
Jun 16, 2026
15w ago
DEFA14A
NEUTRAL ★ 3/10
$0.5600 $0.5300▼ −5.36%▼ −6.21%$0.4400 (−21.43%)
Jun 8, 2026
16w ago
DEFA14A
NEUTRAL ★ 4/10
$0.5800 $0.5502▼ −5.14%▼ −6.53%$0.4400 (−24.14%)
Showing 10 of 21

US Market Status

Market Open — Closes in 49m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access